Why We Invested: NalaGenetics and ending the tyranny of the “average”

--

--

--

Integra Partners invests in early stage companies in the areas of financial services, insurance and healthcare. Visit us at integrapartners.co

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

An app for diabetics by a diabetic is on the App Store

TOP 5 REASONS TO NOT TRUST SCIENTIFIC RESEARCH STUDIES

COVID: The death toll of panic

Sesame Street: An Education in Public Health Messaging

A TV screen shows Big Bird and Oscar the Grouch standing alongside two CommunicateHealth doodles.

November Biohacking Q&A

How a Summer in South Africa Can Strip a Researcher to the Core of Her Humanity

How Healthcare Mobile Apps are Transforming the Healthcare Industry

MI Leg: HB-4052: Oppose: Amend to Standard Time

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Integra Partners

Integra Partners

Integra Partners invests in early stage companies in the areas of financial services, insurance and healthcare. Visit us at integrapartners.co

More from Medium

Ancora: Advancing antibodies from the lab to patient treatments

Time to sharpen your pencils

Announcing our third exit: +Simple

Veriteos × MiSalud